Rob is the Director, Global Indication Lead at Janssen Oncology. Rob, an incredible athlete, became a strong cyclist in 2017 when he joined the inaugural R2V team on the 8-day “Desert Ride” from LA toFlagstaff, AX. In 2018, he re-upped his commitment rode on the Red Rocks team through Utah in 2018. He is back for 2019! Rob saysRoad to Victories empowers the patients who ride in the event to make a difference and allows those of us who get to know them to work even harder to find a cure.”
At Janssen Oncology, we’re shaping the future of cancer treatment. In the process, we’re striving to change expectations of what a cancer diagnosis means. Our purpose is driven by an urgency and commitment to bringing transformational cancer solutions to the people who need them. Passionate about our work, we are driven by the personal connection many of us share with the disease. With our partners, we focus on delivering solutions that make a positive impact on human health. We are part of Janssen Biotech, Inc., and the Janssen Pharmaceutical Companies of Johnson & Johnson.
About Janssen OncologyClick below to learn more about a treatment option for multiple myeloma. If you’re also interested in getting more information from Janssen, sign up for ongoing communications.
Learn More